Skip to main content
. 2022 Mar 23;14(7):1615. doi: 10.3390/cancers14071615

Figure 1.

Figure 1

Timeline of SNA preclinical and clinical development. First-generation SNA architectures focused on gene-regulation and the delivery of chemotherapeutic and imaging agents. Second generation SNAs are liposomal structures designed to active anti-tumor immune responses. Next-generation SNAs are multimodal structures, functionalized with multiple therapeutic cues. Bcl2L12, Bcl2Like12; TMZ, temozolomide; TLR, Toll-like receptor; TNBC, triple negative breast cancer.